| |
| |
|
| Insider
Information: |
Sachdev Amit |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
71,325 |
|
|
Indirect Shares
|
7,447 |
|
|
| Direct
Value |
$24,511,741 |
|
|
|
Indirect Value
|
$3,299,393 |
|
|
| Total
Shares |
78,772 |
|
|
| Total
Value |
$27,811,135 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-05-15 |
55,325 |
2024-05-15 |
7,447 |
Premium* |
|
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-05-06 |
4 |
AS |
$275.28 |
$184,162 |
D/D |
(669) |
35,103 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-05-06 |
4 |
OE |
$131.89 |
$88,234 |
D/D |
669 |
35,772 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-05-11 |
4 |
AS |
$276.25 |
$3,014,014 |
D/D |
(10,665) |
35,103 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-05-11 |
4 |
OE |
$131.89 |
$1,406,607 |
D/D |
10,665 |
45,768 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-05-15 |
4 |
AS |
$274.67 |
$16,496 |
D/D |
(58) |
35,103 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-08-03 |
4 |
AS |
$276.96 |
$540,137 |
D/D |
(1,941) |
35,103 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-08-03 |
4 |
OE |
$86.52 |
$167,935 |
D/D |
1,941 |
37,044 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-11-16 |
4 |
AS |
$222.50 |
$9,388 |
D/D |
(42) |
35,103 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2020-12-08 |
4 |
GD |
$0.00 |
$0 |
I/I |
3,391 |
7,368 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
32,077 |
70,423 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-02-10 |
4 |
D |
$214.16 |
$518,481 |
D/D |
(2,421) |
68,002 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-02-11 |
4 |
AS |
$210.43 |
$939,068 |
D/D |
(4,460) |
63,542 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-02-17 |
4 |
D |
$211.75 |
$1,612,053 |
D/D |
(7,613) |
55,929 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-02-18 |
4 |
AS |
$210.00 |
$1,962,366 |
D/D |
(9,264) |
46,665 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-02-24 |
4 |
D |
$217.57 |
$640,961 |
D/D |
(2,946) |
43,719 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-02-25 |
4 |
AS |
$211.56 |
$765,307 |
D/D |
(3,586) |
40,133 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-04-27 |
4 |
AS |
$215.58 |
$839,193 |
D/D |
(3,884) |
40,133 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-04-27 |
4 |
OE |
$86.52 |
$336,044 |
D/D |
3,884 |
44,017 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-05-17 |
4 |
AS |
$215.59 |
$9,736 |
D/D |
(45) |
40,133 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2021-11-15 |
4 |
AS |
$186.78 |
$9,547 |
D/D |
(51) |
31,928 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
29,638 |
61,566 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2022-02-10 |
4 |
D |
$237.74 |
$592,210 |
D/D |
(2,491) |
59,075 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2022-02-17 |
4 |
D |
$232.51 |
$813,087 |
D/D |
(3,497) |
55,578 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2022-02-24 |
4 |
D |
$227.86 |
$1,678,872 |
D/D |
(7,368) |
48,210 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
• – – |
2022-05-17 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,672 |
11,052 |
0 |
- |
|
193 Records found
|
|
Page 7 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
